Productos

Laboratorios Bagó Briotaz

Briotaz

FORMA FARMACÉUTICA

Comprimidos Recubiertos

COMPOSICIÓN

Cada comprimido recubierto contiene: Ambrisentan 5 mg

ACCIÓN TERAPÉUTICA

Antihipertensivo pulmonar.

INDICACIONES

Briotaz 5 está indicado para el tratamiento de pacientes con hipertensión arterial pulmonar (HAP) clasificados como clase funcional II y III de la Organización Mundial de la Salud (OMS), para mejorar su capacidad para realizar ejercicio. Se ha demostrado la eficacia de este medicamento en HAP idiopática (HAPI) y en HAP asociada a enfermedad del tejido conectivo.

PRESENTACIÓN

Envase por 30 comprimidos recubiertos

Médicos
Array
(
    [ID] => 13530
    [post_author] => 1
    [post_date] => 2017-10-06 12:22:10
    [post_date_gmt] => 2017-10-06 15:22:10
    [post_content] => 

FORMA FARMACÉUTICA

Comprimidos Recubiertos

COMPOSICIÓN

Cada comprimido recubierto contiene: Ambrisentan 5 mg

ACCIÓN TERAPÉUTICA

Antihipertensivo pulmonar.

INDICACIONES

Briotaz 5 está indicado para el tratamiento de pacientes con hipertensión arterial pulmonar (HAP) clasificados como clase funcional II y III de la Organización Mundial de la Salud (OMS), para mejorar su capacidad para realizar ejercicio. Se ha demostrado la eficacia de este medicamento en HAP idiopática (HAPI) y en HAP asociada a enfermedad del tejido conectivo.

PRESENTACIÓN

Envase por 30 comprimidos recubiertos [post_title] => Briotaz [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => briotaz [to_ping] => [pinged] => [post_modified] => 2020-02-26 09:27:15 [post_modified_gmt] => 2020-02-26 12:27:15 [post_content_filtered] => [post_parent] => 0 [guid] => https://www.bago.com.ar/vademecum/?post_type=productos&p=13530 [menu_order] => 0 [post_type] => productos [post_mime_type] => [comment_count] => 0 [filter] => raw [prospecto_para_pacientes] => Array ( [0] => WP_Post Object ( [ID] => 14512 [post_author] => 1 [post_date] => 2020-02-26 09:26:31 [post_date_gmt] => 2020-02-26 12:26:31 [post_content] => [post_title] => Briotaz-informacion-para-pacientes-2020_compressed [post_excerpt] => [post_status] => inherit [comment_status] => open [ping_status] => closed [post_password] => [post_name] => briotaz-informacion-para-pacientes-2020_compressed [to_ping] => [pinged] => [post_modified] => 2020-02-26 09:26:31 [post_modified_gmt] => 2020-02-26 12:26:31 [post_content_filtered] => [post_parent] => 0 [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2020/02/Briotaz-informacion-para-pacientes-2020_compressed.pdf [menu_order] => 0 [post_type] => attachment [post_mime_type] => application/pdf [comment_count] => 0 [filter] => raw ) ) [url_para_mayor_informacion_video] => [url_para_mayor_informacion] => [url_productos_consumo_masivo] => [prospecto] => Array ( [0] => WP_Post Object ( [ID] => 13533 [post_author] => 1 [post_date] => 2017-10-06 12:19:20 [post_date_gmt] => 2017-10-06 15:19:20 [post_content] => [post_title] => briotaz-prospecto [post_excerpt] => [post_status] => inherit [comment_status] => open [ping_status] => closed [post_password] => [post_name] => briotaz-prospecto [to_ping] => [pinged] => [post_modified] => 2017-10-06 12:19:20 [post_modified_gmt] => 2017-10-06 15:19:20 [post_content_filtered] => [post_parent] => 0 [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2017/10/briotaz-prospecto.pdf [menu_order] => 0 [post_type] => attachment [post_mime_type] => application/pdf [comment_count] => 0 [filter] => raw ) ) [presentacion_img] => Array ( ) [logo_img] => Array ( [0] => WP_Post Object ( [ID] => 13535 [post_author] => 1 [post_date] => 2017-10-06 12:19:26 [post_date_gmt] => 2017-10-06 15:19:26 [post_content] => [post_title] => logo-briotaz [post_excerpt] => [post_status] => inherit [comment_status] => open [ping_status] => closed [post_password] => [post_name] => logo-briotaz [to_ping] => [pinged] => [post_modified] => 2017-10-06 12:19:26 [post_modified_gmt] => 2017-10-06 15:19:26 [post_content_filtered] => [post_parent] => 0 [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2017/10/logo-briotaz.png [menu_order] => 0 [post_type] => attachment [post_mime_type] => image/png [comment_count] => 0 [filter] => raw ) ) [foto_producto] => Array ( [0] => WP_Post Object ( [ID] => 13534 [post_author] => 1 [post_date] => 2017-10-06 12:19:24 [post_date_gmt] => 2017-10-06 15:19:24 [post_content] => [post_title] => banners-editable [post_excerpt] => [post_status] => inherit [comment_status] => open [ping_status] => closed [post_password] => [post_name] => banners-editable-3 [to_ping] => [pinged] => [post_modified] => 2017-10-06 12:19:24 [post_modified_gmt] => 2017-10-06 15:19:24 [post_content_filtered] => [post_parent] => 0 [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2017/10/banners-editable.png [menu_order] => 0 [post_type] => attachment [post_mime_type] => image/png [comment_count] => 0 [filter] => raw ) ) [fotos_lanzamiento] => Array ( [0] => WP_Post Object ( [ID] => 13535 [post_author] => 1 [post_date] => 2017-10-06 12:19:26 [post_date_gmt] => 2017-10-06 15:19:26 [post_content] => [post_title] => logo-briotaz [post_excerpt] => [post_status] => inherit [comment_status] => open [ping_status] => closed [post_password] => [post_name] => logo-briotaz [to_ping] => [pinged] => [post_modified] => 2017-10-06 12:19:26 [post_modified_gmt] => 2017-10-06 15:19:26 [post_content_filtered] => [post_parent] => 0 [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2017/10/logo-briotaz.png [menu_order] => 0 [post_type] => attachment [post_mime_type] => image/png [comment_count] => 0 [filter] => raw ) ) [especialidad] => Array ( ) [marca] => Array ( [0] => Briotaz ) [principio_activo] => Array ( [0] => Ambrisentan ) [post_content_formatted] =>

FORMA FARMACÉUTICA

Comprimidos Recubiertos

COMPOSICIÓN

Cada comprimido recubierto contiene: Ambrisentan 5 mg

ACCIÓN TERAPÉUTICA

Antihipertensivo pulmonar.

INDICACIONES

Briotaz 5 está indicado para el tratamiento de pacientes con hipertensión arterial pulmonar (HAP) clasificados como clase funcional II y III de la Organización Mundial de la Salud (OMS), para mejorar su capacidad para realizar ejercicio. Se ha demostrado la eficacia de este medicamento en HAP idiopática (HAPI) y en HAP asociada a enfermedad del tejido conectivo.

PRESENTACIÓN

Envase por 30 comprimidos recubiertos

)

Información del producto

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/briotaz-prospecto.pdf
        )

)
Ver Prospecto >
Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2020/02/Briotaz-informacion-para-pacientes-2020_compressed.pdf
        )

)
Ver Info Pacientes >

Bibliografía

Ver todos >
anexo_congre_single

ADVERTENCIA:

El material incluido en este sitio ha sido concebido exclusivamente para los profesionales de la salud con fines informativos, y destinado a orientar sobre el uso adecuado de los medicamentos y a satisfacer sus necesidades de mayor información.

Todos los textos referidos a nuestros productos de venta bajo prescripción médica se corresponden a los lineamientos aprobados por la Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT).

Laboratorios Bagó le sugiere consultar siempre a un profesional de la salud calificado ante cualquier duda sobre una condición médica particular.

He comprendido y deseo ver la información

Consultas médicas: infoproducto@bago.com.ar